基于生理学的吸收建模,以预测两个apixaban配方的生物等价性
Ting Luo1, Lu Wang1, Zourong Ruan1
1Center of Clinical Pharmacology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Clinical and translational science
|May 15, 2024
概括
基于生理学的吸收建模准确预测了阿皮克萨班配方的生物等价性 (BE). 这种虚拟BE模拟方法最大限度地减少了冗余的体内研究的需要,支持仿制药的开发.
科学领域:
- 药理动力学和药物新陈代谢
- 计算机建模和模拟
- 制药科学 制药科学
背景情况:
- 仿制药的治疗可比性依赖于在吸收速度和程度上证明生物等价性 (BE).
- 生物等价性研究对于仿制药的批准和市场推广至关重要.
- 虚拟BE模拟提供了一个风险减轻策略,以优化体内BE研究设计.
研究的目的:
- 开发和验证一个基于生理学的吸收模型,用于虚拟生物等价性模拟.
- 使用开发的模型预测阿皮克萨班试验和参考配方的生物等价性.
- 评估基于生理学的吸收建模在配方选和风险评估中的有用性.
主要方法:
- 基于生理学的吸收模型的开发.
- 该模型的应用用于apixaban配方的虚拟生物等价性模拟.
- 与现有的临床生物等价性研究数据进行in silico预测的比较.
主要成果:
- 开发的基于生理学的吸收模型准确地预测了阿皮克萨班试验和参考配方的生物等价性.
- 模型预测与既定的临床研究结果一致,无论是在禁食和食条件下.
- 虚拟BE模拟成功证实了测试的配方之间的生物等价性.
结论:
- 基于生理学的吸收建模是预测药物产品生物等价性的有效工具.
- 虚拟BE模拟可以指导配方开发,并减少广泛的体内试验的必要性.
- 这种建模方法作为一种有价值的方法和风险评估策略,用于识别潜在的临床生物等价性问题.
相关概念视频
Bioequivalence: Overview
1.0K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.0K
Pharmacokinetic Models: Comparison and Selection Criterion
69
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
69
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
38
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
38
One-Compartment Open Model for Extravascular Administration: First-Order Absorption Model
214
The first-order absorption model for extravascular administration describes the rate at which a drug is absorbed and eliminated, following the principles of first-order kinetics. This model is vital as it provides a mathematical representation of drug behavior within the body. It also allows for the prediction and interpretation of drug absorption and elimination based on the rate of change in drug concentration over time. This model can be visualized as a plasma concentration-time profile...
214
Physiological Pharmacokinetic Models: Assumption with Protein Binding
41
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
41
Factors Influencing Drug Absorption: Physicochemical Parameters
263
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
263


